Dr. Steven Joseph Saccaro, MD

Dr. Saccaro practices at Ochsner Lafayette General Medical Center in Lafayette, Louisiana, part of Ochsner Health System.

Dr. Saccaro's NPI, 1194728543, was assigned on May 31, 2005. Dr. Saccaro holds Louisiana license MD024855.

Dr. Saccaro's primary practice is Ochsner Lafayette General Medical Center, at 1214 Coolidge Avenue, Lafayette, LA 70503 in Lafayette Parish. The practice phone is (337) 289-7991.

Dr. Saccaro's primary practice is Ochsner Lafayette General Medical Center in Lafayette, Louisiana, part of Ochsner Health System. Dr. Saccaro is also affiliated with Our Lady of Lourdes Regional Medical Center. The medical group on file is Family Health Plaza. Dmand AI also links Dr. Saccaro to 3 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Saccaro practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Saccaro's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Saccaro is licensed in Louisiana.

CMS data shows 808 Medicare services from Dr. Saccaro across 8 procedure codes in 2024, for 272 Medicare patients. Medicare paid $58,280 for them.

CMS counts 272 Medicare patients who saw Dr. Saccaro in 2024. The largest group is 65 to 74, with 123 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Saccaro's median patient age at 68, with 53% women.

In 2024, Dr. Saccaro wrote 814 Medicare Part D claims for 180 patients. 79% of them were for generic drugs. CMS names the drug for 603 of them, across 25 drugs with 11 or more claims each, at $1,183,979 in total drug cost. In 2023, CMS named 652 claims across 24 drugs.

Dr. Saccaro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Saccaro as offering telehealth.

Dmand AI links 1 paper to Dr. Saccaro in 2023. Dr. Saccaro's most frequent co-authors are Adil Jamal Akhtar, MD, Warren Le Eric Alexander, MD and Savitha Balaraman, MD.

Dmand AI links Dr. Saccaro to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Male, Carcinoma, Non-Small-Cell Lung and Melanoma.

CMS Open Payments shows 241 general payments to Dr. Saccaro from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Novartis Pharmaceuticals Corporation paid the most, $575.